Like Alzheimer's disease (AD), the prion diseases are age-dependent degenerative disorders of the central nervous system (CNS). These dementing diseases are among the most dreaded afflictions from which older people frequently suffer. Studies on both the familial and sporadic forms of AD have been slow, in part, due to our lack of suitable animal models. In contrast, the availability of animal models for neurodegenerative diseases caused by prions has led to relatively rapid advances. Indeed, prion diseases have become the most well understood CNS degenerative disorders of delayed onset and they are the focus of this proposal. In humans, prion diseases generally occur in order adults but the mechanism governing their time of onset is unknown. An enlarging body of evidence argues that prion diseases are disorders of protein conformation. Investigations directed toward elucidating the role of molecular chaperones in the conversion of the cellular prion protein (PrPC) into the scrapie isoform (PrPSc) are proposed (Project 1). These studies extend recent findings showing that scrapie infection of cultured cells is accompanied by a profound change in the stress response; many stress proteins appear to function as chaperones. Studies of prion infected cultured cells also suggest that alterations in membranes, as manifest by changes in Ca2+ transport and lipid flux, may underlie the neuropathology of these disorders (Project 2). The neuropathology of experimental prion diseases in mice has been known for many years to be controlled, at least in part, by """"""""strains"""""""" or different isolates of prions. Investigations of prion strains focus on one of the most challenging and enigmatic aspects of these disorders. Whether individual strains of prions represent different conformers of PrPSc remains to be established. To test this hypothesis, several new approaches to studies of the molecular basis of prion strains are proposed including the use of transgenic (Tg) mice expressing chimeric Syrian hamster (SHa)/mouse (Mo) PrP genes as well as Tg and PrP gene targeted hamsters (Project 3). The higher concentrations of PrPSc in SHa brains offer an important advantage in protein structure studies while the mice expressing chimeric SHa/Mo PrP transgenes allow the transfer of Mo prion strains into hamsters. These investigations are closely tied to investigations of PrP structure which utilize recombinant and solid phase synthesis of large peptides as well as full length proteins for analysis by spectroscopy, bioassays of scrapie infectivity (Project 4) and NMR (Project 5). Determining the structures of PrPC and PrPSc by solution and solid state NMR are important goals of this application. The diverse skills, talents and backgrounds of the investigators in the proposed program offer an unusual opportunity to define the molecular mechanisms responsible for neurodegeneration in prion diseases. Elucidation of the mechanisms by which brain cells cease to function and die in prion diseases after a long delay may offer new approaches to elucidating the etiologies of more prevalent neurodegenerative disorders afflicting older people, including AD.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG010770-07
Application #
2899759
Study Section
Special Emphasis Panel (ZAG1-PCR-5 (03))
Project Start
1993-04-01
Project End
2000-03-31
Budget Start
1999-04-01
Budget End
2000-03-31
Support Year
7
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Neurology
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
O'Brien, Connor J; Droege, Daniel G; Jiu, Alexander Y et al. (2018) Photoredox Cyanomethylation of Indoles: Catalyst Modification and Mechanism. J Org Chem 83:8926-8935
Condello, Carlo; Lemmin, Thomas; Stöhr, Jan et al. (2018) Structural heterogeneity and intersubject variability of A? in familial and sporadic Alzheimer's disease. Proc Natl Acad Sci U S A 115:E782-E791
Woerman, Amanda L; Kazmi, Sabeen A; Patel, Smita et al. (2018) MSA prions exhibit remarkable stability and resistance to inactivation. Acta Neuropathol 135:49-63
Lim, Kwang Hun; Dasari, Anvesh K R; Hung, Ivan et al. (2016) Structural Changes Associated with Transthyretin Misfolding and Amyloid Formation Revealed by Solution and Solid-State NMR. Biochemistry 55:1941-4
Elkins, Matthew R; Wang, Tuo; Nick, Mimi et al. (2016) Structural Polymorphism of Alzheimer's ?-Amyloid Fibrils as Controlled by an E22 Switch: A Solid-State NMR Study. J Am Chem Soc 138:9840-52
Watts, Joel C; Giles, Kurt; Saltzberg, Daniel J et al. (2016) Guinea Pig Prion Protein Supports Rapid Propagation of Bovine Spongiform Encephalopathy and Variant Creutzfeldt-Jakob Disease Prions. J Virol 90:9558-9569
Dunn, Joshua G; Weissman, Jonathan S (2016) Plastid: nucleotide-resolution analysis of next-generation sequencing and genomics data. BMC Genomics 17:958
Giles, Kurt; Berry, David B; Condello, Carlo et al. (2016) Optimization of Aryl Amides that Extend Survival in Prion-Infected Mice. J Pharmacol Exp Ther 358:537-47
Patzke, Christopher; Acuna, Claudio; Giam, Louise R et al. (2016) Conditional deletion of L1CAM in human neurons impairs both axonal and dendritic arborization and action potential generation. J Exp Med 213:499-515
Ahlenius, Henrik; Chanda, Soham; Webb, Ashley E et al. (2016) FoxO3 regulates neuronal reprogramming of cells from postnatal and aging mice. Proc Natl Acad Sci U S A 113:8514-9

Showing the most recent 10 out of 179 publications